森萱医药
(920946)
| 流通市值：46.01亿 | | | 总市值：46.02亿 |
| 流通股本：4.27亿 | | | 总股本：4.27亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 513,705,935.39 | 542,819,120.29 | 542,877,681.42 | 479,118,465.9 |
| 交易性金融资产 | 146,987,857.95 | 144,541,972.02 | 128,438,484.18 | 154,637,921.11 |
| 应收票据及应收账款 | 86,732,872.24 | 89,675,303.94 | 77,212,513.42 | 81,056,317.36 |
| 其中：应收票据 | 19,844,072.66 | 17,446,508.37 | 14,337,623.47 | 14,275,589.12 |
| 应收账款 | 66,888,799.58 | 72,228,795.57 | 62,874,889.95 | 66,780,728.24 |
| 应收款项融资 | 27,985,052.54 | 33,146,019.72 | 33,288,238.32 | 34,512,941.25 |
| 预付款项 | 3,940,459.46 | 5,899,688.02 | 3,049,196.62 | 3,712,758.77 |
| 其他应收款合计 | 240,110.05 | 188,160.08 | 167,100.27 | 127,670.97 |
| 存货 | 94,573,835.5 | 97,689,233.85 | 108,778,088.67 | 112,279,118.16 |
| 其他流动资产 | 292,402.56 | 376,016.39 | 363,875.18 | 118,508.34 |
| 流动资产合计 | 874,458,525.69 | 914,335,514.31 | 894,175,178.08 | 865,563,701.86 |
| 非流动资产: | | | | |
| 固定资产 | 279,460,641.65 | 288,056,452.62 | 296,641,206.47 | 307,534,150.11 |
| 在建工程 | 6,565,721.22 | 3,137,129.56 | 2,519,194.38 | 2,125,851.49 |
| 使用权资产 | 3,149,284.38 | 3,314,146.91 | 793,837.71 | 934,976.83 |
| 无形资产 | 33,877,655.06 | 34,167,745.45 | 34,457,835.83 | 34,747,926.22 |
| 递延所得税资产 | 5,508,654.99 | 5,449,967.42 | 5,921,703.06 | 5,802,954.43 |
| 其他非流动资产 | 261,553,844.47 | 242,150,010.6 | 209,306,109.85 | 185,705,115.37 |
| 非流动资产合计 | 590,115,801.77 | 576,275,452.56 | 549,639,887.3 | 536,850,974.45 |
| 资产总计 | 1,464,574,327.46 | 1,490,610,966.87 | 1,443,815,065.38 | 1,402,414,676.31 |
| 流动负债: | | | | |
| 短期借款 | 13,005,500 | 3,000,000 | - | - |
| 应付票据及应付账款 | 24,868,628.35 | 27,336,435.89 | 35,228,750.87 | 32,202,165.5 |
| 应付账款 | 24,868,628.35 | 27,336,435.89 | 35,228,750.87 | 32,202,165.5 |
| 合同负债 | 3,840,131.51 | 8,733,358.37 | 9,488,507.8 | 4,129,386.98 |
| 应付职工薪酬 | 18,946,132.93 | 17,414,640.84 | 27,600,539.94 | 20,506,898.93 |
| 应交税费 | 10,276,733 | 13,126,545.25 | 5,748,844.48 | 9,769,520.23 |
| 其他应付款合计 | 6,197,758.42 | 6,331,763.96 | 7,161,896.03 | 6,340,535.86 |
| 其中:应付利息 | - | 2,750 | - | - |
| 一年内到期的非流动负债 | 1,039,951.93 | 941,331.75 | 211,900.98 | 143,674.88 |
| 其他流动负债 | 10,171,541.77 | 9,566,643.06 | 8,362,543.91 | 8,760,832.34 |
| 流动负债合计 | 88,346,377.91 | 86,450,719.12 | 93,802,984.01 | 81,853,014.72 |
| 非流动负债: | | | | |
| 租赁负债 | 1,570,254.13 | 2,500,672.11 | 540,771.15 | 472,413.06 |
| 递延收益 | 1,999,792.59 | 2,053,798.41 | 2,107,804.23 | 2,161,810.05 |
| 递延所得税负债 | 5,718,601.44 | 5,978,358.29 | 5,683,156.51 | 3,684,657.35 |
| 非流动负债合计 | 9,288,648.16 | 10,532,828.81 | 8,331,731.89 | 6,318,880.46 |
| 负债合计 | 97,635,026.07 | 96,983,547.93 | 102,134,715.9 | 88,171,895.18 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 426,918,340 | 426,918,340 | 426,918,340 | 426,918,340 |
| 资本公积 | 219,521,521.18 | 219,100,989.43 | 218,680,457.68 | 218,259,925.93 |
| 专项储备 | 4,184,358.06 | 3,734,289.52 | 2,481,386.11 | 4,575,058.11 |
| 盈余公积 | 56,035,528.72 | 56,035,528.72 | 56,035,528.72 | 49,089,945.29 |
| 未分配利润 | 583,223,251.19 | 608,194,339.52 | 561,147,599.01 | 540,264,673.34 |
| 归属于母公司股东权益合计 | 1,289,882,999.15 | 1,313,983,487.19 | 1,265,263,311.52 | 1,239,107,942.67 |
| 少数股东权益 | 77,056,302.24 | 79,643,931.75 | 76,417,037.96 | 75,134,838.46 |
| 股东权益合计 | 1,366,939,301.39 | 1,393,627,418.94 | 1,341,680,349.48 | 1,314,242,781.13 |
| 负债和股东权益合计 | 1,464,574,327.46 | 1,490,610,966.87 | 1,443,815,065.38 | 1,402,414,676.31 |
| 公告日期 | 2026-08-26 | 2026-04-29 | 2026-04-22 | 2025-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |